March 15, 2016
Eli Lilly and Company has filed a lawsuit in Tokyo demanding a court injunction against the launch of all Evista (raloxifene) generic versions approved in February. The US giant had filed a similar suit against Sawai Pharmaceutical’s generic version last...read more